Condition: Gonorrhea · Chlamydia · Syphilis · Sponsor: Westat
The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.
This description comes directly from the study's public registry record.
Nancy Liu · 718-980-3937 · NancyLiu@westat.com
Erin Ricketts · 240-453-2786 · ErinRicketts@westat.com
Always discuss trial participation with your own doctor first.
| UCLA Care | Los Angeles, California, United States | Not Yet Recruiting |
| San Francisco Department of Public Health | San Francisco, California, United States | Recruiting |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | Recruiting |
| University of Florida | Tampa, Florida, United States | Recruiting |
| Ponce de Leon | Atlanta, Georgia, United States | Not Yet Recruiting |
| University Illinois Chicago | Chicago, Illinois, United States | Recruiting |
| Tulane University | New Orleans, Louisiana, United States | Not Yet Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Not Yet Recruiting |
| Harlem Prevention Center | New York, New York, United States | Not Yet Recruiting |
| Chapel Hill | Chapel Hill, North Carolina, United States | Not Yet Recruiting |
| Penn Prevention | Philadelphia, Pennsylvania, United States | Not Yet Recruiting |
| St. Jude Children's Research Hospital | Memphis, Tennessee, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06738407